Adrenergic alpha-1 pathway is associated with hypertension among nigerians in a pathway-focused analysis

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Reder, Nicholas P ^a   Tayo, Bamidele O ^a   Salako, Babatunde ^b   Ogunniyi, Adesola ^b   Adeyemo, Adebowale ^c   Rotimi, Charles ^c   Cooper, Richard S ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR;

ADRA1A GENE; ADRA1B GENE; ADRA1D GENE; ADULT; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ETHNIC GROUP; FEMALE; GENE; GENE FUNCTION; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; MALE; NIGERIAN; PATHOGENESIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIGERIA; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, ALPHA-1; SIGNAL TRANSDUCTION;

EID: 84861205619     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037145     Document Type: Article

References (33)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, et al. (2005) Global burden of hypertension: Analysis of worldwide data. Lancet 365 (9455): 217-223.
2. Harrap SB, (1994) Hypertension: Genes versus environment. Lancet 344 (8916): 169-171.
3. Collins FS, McKusick VA, (2001) Implications of the human genome project for medical science. JAMA 285 (5): 540-544.
4. Hindorff LA, Junkins HA, Hall PN, Mehta JP, Manolio TA, (2011) A catalog of published genome-wide association studies. available at: www.genome.gov/gwastudies.
5. Hunter DJ, Kraft P, (2007) Drinking from the fire hose-statistical issues in genomewide association studies. N Engl J Med 357 (5): 436-439.
6. Rafiq S, Anand S, Roberts R, (2010) Genome-wide association studies of hypertension: Have they been fruitful? J Cardiovasc Transl Res 3 (3): 189-196.
7. Torkamani A, Topol EJ, Schork NJ, (2008) Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 92 (5): 265-272.
8. Sober S, Org E, Kepp K, Juhanson P, Eyheramendy S, et al. (2009) Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array. PLoS One 4 (6): e6034.
9. Eleftherohorinou H, Wright V, Hoggart C, Hartikainen AL, Jarvelin MR, et al. (2009) Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases. PLoS One 4 (11): e8068.
10. Cooper R, Rotimi C, Ataman S, McGee D, Osotimehin B, et al. (1997) The prevalence of hypertension in seven populations of west african origin. Am J Public Health 87 (2): 160-168.
11. Rotimi CN, Dunston GM, Berg K, Akinsete O, Amoah A, et al. (2001) In search of susceptibility genes for type 2 diabetes in west africa: The design and results of the first phase of the AADM study. Ann Epidemiol 11 (1): 51-58.
12. Cooper R, Puras A, Tracy J, Kaufman J, Asuzu M, et al. (1997) Evaluation of an electronic blood pressure device for epidemiological studies. Blood Press Monit 2 (1): 35-40.
13. Kang SJ, Chiang CW, Palmer CD, Tayo BO, Lettre G, et al. (2010) Genome-wide association of anthropometric traits in african- and african-derived populations. Hum Mol Genet 19 (13): 2725-2738.
14. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR, (2005) Adjusting for treatment effects in studies of quantitative traits: Antihypertensive therapy and systolic blood pressure. Stat Med 24 (19): 2911-2935.
15. Clayton D, (2008) Testing for association on the X chromosome. Biostatistics 9 (4): 593-600.
16. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 (3): 559-575.
17. Liu JZ, McRae AF, Nyholt DR, Medland SE, Wray NR, et al. (2010) A versatile gene-based test for genome-wide association studies. Am J Hum Genet 87 (1): 139-145.
18. Morris AP, Zeggini E, (2010) An evaluation of statistical approaches to rare variant analysis in genetic association studies. Genet Epidemiol 34 (2): 188-193.
19. International Consortium for Blood Pressure Genome-Wide Association Studies, Ehret GB, Munroe PB, Rice KM, Bochud M, et al. (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478 (7367): 103-109.
20. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, et al. (2009) Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 41 (6): 666-676.
21. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, et al. (2009) Genome-wide association study of blood pressure and hypertension. Nat Genet 41 (6): 677-687.
22. Krushkal J, Xiong M, Ferrell R, Sing CF, Turner ST, et al. (1998) Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet 7 (9): 1379-1383.
23. Hilbert P, Lindpaintner K, Beckmann JS, Serikawa T, Soubrier F, et al. (1991) Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature 353 (6344): 521-529.
24. Jacob HJ, Lindpaintner K, Lincoln SE, Kusumi K, Bunker RK, et al. (1991) Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 67 (1): 213-224.
25. McCarthy MI, (2008) Casting a wider net for diabetes susceptibility genes. Nat Genet 40 (9): 1039-1040.
26. Cooper RS, Kaufman JS, Ward R, (2003) Race and genomics. N Engl J Med 348 (12): 1166-1170.
27. Kunz R, Kreutz R, Beige J, Distler A, Sharma AM, (1997) Association between the angiotensinogen 235T-variant and essential hypertension in whites: A systematic review and methodological appraisal. Hypertension 30 (6): 1331-1337.
28. Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, et al. (1994) Angiotensinogen gene in human hypertension. lack of an association of the 235T allele among african americans. Hypertension 24 (5): 591-594.
29. Exner DV, Dries DL, Domanski MJ, Cohn JN, (2001) Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med 344 (18): 1351-1357.
30. Papademetriou V, Kaoutzanis C, Dumas M, Pittaras A, Faselis C, et al. (2009) Protective effects of angiotensin-converting enzyme inhibitors in high-risk african american men with coronary heart disease. J Clin Hypertens (Greenwich) 11 (11): 621-626.
31. Ferdinand KC, (2009) Underutilization of angiotensin-converting enzyme inhibitors in high-risk blacks: A case of missed opportunities. J Clin Hypertens (Greenwich) 11 (11): 648-650.
32. Jorde LB, Wooding SP, (2004) Genetic variation, classification and 'race'. Nat Genet 36(11 Suppl) pp. S28-33.
33. Ritchie MD, (2011) Using biological knowledge to uncover the mystery in the search for epistasis in genome-wide association studies. Ann Hum Genet 75 (1): 172-182.